Cytokine-induced megakaryocytic differentiation is regulated by genome-wide loss of a uSTAT transcriptional program

Hyun Jung Park1, Juan Li1, Rebecca Hannah1

  • 1Cambridge Institute for Medical Research, Wellcome Trust/MRC Stem Cell Institute, Cambridge, UK Department of Haematology, University of Cambridge, Cambridge, UK.

The EMBO Journal
|December 25, 2015
PubMed

Insights

Tyrosine-unphosphorylated STAT5 (uSTAT5) normally represses megakaryocyte development. Thrombopoietin (TPO) triggers STAT5 phosphorylation, releasing this repression and activating new gene programs for cell growth and survival.

Area of Science:

  • Cellular and Molecular Biology
  • Developmental Biology
  • Hematopoiesis

Background:

  • Metazoan development relies on transcriptional networks responding to extracellular signals like cytokines.
  • The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is a conserved signaling module activated by cytokines.
  • The precise mechanisms by which STAT activation influences lineage-specific transcriptional programs remain incompletely understood.

Purpose of the Study:

  • To elucidate how STAT5 activation modulates megakaryocytic transcriptional programs.
  • To investigate the role of tyrosine-unphosphorylated STAT5 (uSTAT5) in regulating megakaryopoiesis.
  • To understand the dual transcriptional outcomes of STAT5 phosphorylation in response to thrombopoietin (TPO).

Main Methods:

  • Chromatin immunoprecipitation sequencing (ChIP-seq) to map STAT5 and CTCF genome-wide.
  • Analysis of gene expression changes in response to TPO stimulation.
  • Co-localization studies of STAT5, CTCF, and ERG at target gene loci.

Main Results:

  • In the absence of TPO, uSTAT5 resides in the nucleus, colocalizes with CTCF, and actively represses megakaryocytic gene expression.
  • TPO-induced STAT5 phosphorylation causes its genome-wide relocation to specific DNA binding sites.
  • This relocation leads to the release of uSTAT5-mediated repression and the activation of pSTAT5-driven programs regulating apoptosis and proliferation.
  • uSTAT5-mediated repression is achieved by restricting the access of the transcription factor ERG to its target genes.

Conclusions:

  • STAT5 exhibits a dual role in megakaryopoiesis, acting as a repressor in its unphosphorylated state and an activator upon phosphorylation.
  • uSTAT5 functions as a transcriptional repressor by limiting the binding of key lineage-specific transcription factors like ERG.
  • This study reveals a novel mechanism of cytokine-mediated differentiation through the dynamic regulation of STAT5's transcriptional activity and genomic localization.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.9K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.8K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.3K
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
4.6K